In September 2025, Medtronic announced it had received FDA approval and launched the Altaviva device, a minimally invasive ...

MDT gains FDA approval for its Altaviva device, a minimally invasive bladder control therapy with long-lasting benefits.

Medtronic's Altaviva wins FDA approval as a minimally invasive implant for urge urinary incontinence, offering long-lasting ...

Inserted near the ankle in a minimally invasive procedure, the device generates low-level electronic impulses that stimulate ...

Patients who receive an Altaviva device return home with therapy activated. Medtronic says this marks a first among ...

The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks GALWAY ...

Medtronic (NYSE: MDT) today reported the first patient treated with its Altaviva neuromodulation device for urge urinary incontinence.

Stereotaxis (AMEX: STXS) announces first procedures with Genesis Robotic Magnetic Navigation System for minimally invasive ...

(MENAFN- GlobeNewsWire - Nasdaq) The overactive bladder treatment market is experiencing steady growth driven by the increasing prevalence of OAB, especially among the aging population. Rising ...

Having trouble with bladder control? There might be an app for that, researchers say. Female veterans suffering from urinary incontinence received effective relief using a smartphone app called ...

Both a smartphone app and a telehealth visit helped female veterans manage urinary incontinence The app produced earlier results, but ultimately both approaches were equally effective THURSDAY, Sept.